LifeOS Genomics

The QLoci md1000 Analyzer provides the only liquid biopsy testing platform capable of combining high clinically relevant multiplexing, 0.01% or better sensitivity, and absolute quantitation of biomarkers. Experts indicate that approximately half of lung cancer patients have EGFR gene mutations. LifeOS’ QLoci system offers 0.01% sensitivity assay panels with sample-to-result workflows. Our patented mdPCR technology is a fast and reliable way to quantify large numbers of targets of interest in a single sample of nucleic acid. We offer an unique platform for medical laboratories, researchers, and hospital systems who think bigger for their clinical applications.